Summit Wealth & Retirement Planning’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,755
Closed -$289K 108
2022
Q2
$289K Sell
3,755
-200
-5% -$15.2K 0.11% 91
2022
Q1
$289K Buy
3,955
+120
+3% +$8.06K 0.1% 87
2021
Q4
$239K Sell
3,835
-1,045
-21% -$61.3K 0.08% 83
2021
Q3
$289K Sell
4,880
-50
-1% -$3.29K 0.11% 75
2021
Q2
$329K Sell
4,930
-7,031
-59% -$458K 0.12% 70
2021
Q1
$755K Sell
11,961
-155
-1% -$9.64K 0.28% 55
2020
Q4
$752K Hold
12,116
0.29% 62
2020
Q3
$730K Sell
12,116
-100
-0.8% -$6.02K 0.31% 57
2020
Q2
$718K Sell
12,216
-400
-3% -$23.9K 0.34% 56
2020
Q1
$703K Sell
12,616
-200
-2% -$12.2K 0.38% 57
2019
Q4
$823K Buy
12,816
+6,401
+100% +$367K 0.37% 58
2019
Q3
$325K Buy
6,415
+1
+0% +$47 0.2% 95
2019
Q2
$291K Buy
6,414
+1
+0% +$47 0.17% 107
2019
Q1
$306K Sell
6,413
-18
-0.3% -$897 0.18% 108
2018
Q4
$334K Buy
+6,431
New +$346K 0.25% 81

Other funds holding BMY

Summit Wealth & Retirement Planning's BMY Position: Q3 2022 in Review

Summit Wealth & Retirement Planning sold out of Bristol-Myers Squibb (BMY) in Q3 2022, closing a stake of 3,755 shares — an estimated $289K sold.

Summit Wealth & Retirement Planning first reported a position in BMY in Q4 2018 and held it in 15 quarters. The position peaked at $823K in Q4 2019. 2,469 funds tracked by Wall St. Rank hold BMY as of Q3 2022.

  • Summit Wealth & Retirement Planning reported no remaining Bristol-Myers Squibb position as of Q3 2022 after selling out during the quarter.
  • Summit Wealth & Retirement Planning sold 3,755 Bristol-Myers Squibb shares in Q3 2022, an estimated $289K.
  • Summit Wealth & Retirement Planning first reported a position in Bristol-Myers Squibb in Q4 2018 and held it in 15 quarters.
  • Summit Wealth & Retirement Planning's Bristol-Myers Squibb position peaked at $823K in Q4 2019.
  • 2,469 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.

Based on Summit Wealth & Retirement Planning's 13F filing for Q3 2022, filed 14 Nov 2022.